Edition:
India

Sorrento Therapeutics Inc (SRNE.OQ)

SRNE.OQ on NASDAQ Stock Exchange Capital Market

5.75USD
16 Jan 2018
Change (% chg)

$0.80 (+16.16%)
Prev Close
$4.95
Open
$5.10
Day's High
$5.82
Day's Low
$5.05
Volume
803,559
Avg. Vol
260,255
52-wk High
$5.82
52-wk Low
$1.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 121.91 0.442
Jun '17 4.66 -0.202
Mar '17 4.87 -0.453
FY 2016 Dec '16 4.02 -0.204
Sep '16 2.24 0.239
Jun '16 0.90 -0.931
Mar '16 0.99 -0.412
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 3.60 3.60 3.60 --
Quarter Ending Jun-18 1 4.50 4.50 4.50 --
Year Ending Dec-18 1 23.22 23.22 23.22 --
Earnings (per share)
Quarter Ending Mar-18 1 -0.29 -0.29 -0.29 --
Quarter Ending Jun-18 1 -0.28 -0.28 -0.28 --
Year Ending Dec-18 1 -1.06 -1.06 -1.06 --
LT Growth Rate (%) 1 37.00 37.00 37.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 77.60 160.69 72.80
EPS (TTM) % 2.53 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Sorrento Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.04%
# of Holders: 55
Total Shares Held: 10,345,594
3 Mo. Net Change: -39,458
# New Positions: 1
# Closed Positions: 2
# Increased Positions: 1
# Reduced Positions: 2
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.